Relmada Therapeutics Ownership & Insider Activity

Relmada Therapeutics (RLMD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.6% of shares outstanding. Institutional investors hold 28.2%. Over the past 90 days, insiders made 2 purchases worth $1.7M.

Shares Outstanding

106.670M

Shares Float

100.457M

Insider Shares Owned

3.845M

Insider % Owned

3.6%

Institutional Shares Held

30.118M

Institutional % Held

28.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$1.7M total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$1.7M

Relmada Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 9, 2026	Maged Shenouda	CHIEF FINANCIAL OFFICER	BUY	200.000K	$4.22	$844K
Sep 9, 2026	Sergio Traversa	CHIEF EXECUTIVE OFFICER	BUY	200.000K	$4.14	$828K

Congressional Trading Activity

See all government trades →

Date	Member	Party	Chamber	Action	Amount
Dec 12, 2022	Chris Jacobs	R	House	Sale	$1,001 - $15,000

Relmada Therapeutics Inc